ORLLYMET-GV 1.3 Billyford
-500-mg,-Glimepiride-1-mg-&-Voglibose-0.3-mg-Tablets.jpg "ORLLYMET-GV 1.3 Billyford")
Metformin HCL (Sustained Release) 500 mg, Glimepiride 1 mg & Voglibose 0.3 mg Tablets
Brand :- ORLLYMET-GV 1.3 Billyford
Pack Size : 20X10
Pack Type : BLISTER
Description :
ORLLYMET-GV 1.3 Billyford Tablets combine Metformin HCL (SR) 500 mg, Glimepiride 1 mg, and Voglibose 0.3 mg for the effective management of Type 2 Diabetes. Metformin helps reduce glucose production in the liver and improves insulin sensitivity, Glimepiride stimulates insulin release from the pancreas, and Voglibose delays carbohydrate absorption in the intestine to control post-meal blood sugar spikes. This triple-combination therapy helps achieve better glycemic control and supports long-term diabetes management when taken under medical supervision.
Products
-&-Voglibose-0.3-mg-Tablets.jpg "GLYZORLLY-MV 0.3")
-&-Voglibose-0.2-mg-Tablets.jpg "GLYZORLLY-MV 0.2")
-and-Metformin-Hydrochloride-(Sustained-Release)-Tablets.jpg "GLYZORLLY-60M")
-Tablets.jpg "GLIMPZY-MP2 SR")
-Tablets-IP.jpg "GLIMPZY-MF1 500SR")
-Tablets.jpg "GLIMPZY-MF1 1000 SR")
-TABLETS.jpg "GLIMPZY-MF2/1000SR")
-Tablets.jpg "GLIMPZY-MP1 SR")
-Tablets-(450-mg-Diosmin-+-50-mg-Hesperidin).jpg "DAFLOFINE 500 mg")
-Tablets.jpg "DAPAGLYFORD-5M FORTE")
-Tablets.jpg "DAPAGLYFORD-M 10/500SR")
-Tablets.jpg "DAPAGLYFORD-10M FORTE")
-Tablets.jpg "DAPAGLYFORD-GM1 XR")
-Tablets.jpg "DAPAGLYFORD-GM2 XR")
-Tablets.jpg "DAPAGLYFORD-M 5/500SR")
-1000-mg-Tablets.jpg "Sitablast DM Forte")
-500-mg-Tablets.jpg "Sitablast DM")
-Tablets.jpg "SITABLAST-M SR 50/500")
-1000-mg-Tablets.jpg "Tenoliglipt-M 20/1000")
ORLLYFORD